Norovirus conjures a nightmarish collection of gastrointestinal signs, and the hated an infection has been rampant this winter. The so-called abdomen flu—though it’s unrelated to influenza—strikes immediately and curses its victims with one to a few days of diarrhea and vomiting.
But in contrast to different commonplace infections resembling seasonal flu and COVID, no vaccine exists to assist folks keep away from being sidelined by norovirus, a notoriously transmissible and resilient virus that’s tough to kill with widespread alcohol-based disinfectants. Vaccine builders have lengthy labored to create a vaccine—some seven totally different candidates are at the moment in numerous phases of medical trials. However none has proved efficient sufficient to earn approval within the U.S. There are a number of scientific boundaries, however researchers hope that quickly one method will meet the problem and supply an efficient software to those that need to enhance their immune system in opposition to the nasty an infection.
What Is Norovirus?
On supporting science journalism
For those who’re having fun with this text, contemplate supporting our award-winning journalism by subscribing. By buying a subscription you might be serving to to make sure the way forward for impactful tales concerning the discoveries and concepts shaping our world right now.
Norovirus is liable for greater than half of foodborne sickness circumstances within the U.S. The virus can survive for as much as two weeks on surfaces, prospers within the face of widespread hand sanitizers and rips by way of settings resembling cruise ships and cafeterias. Typical signs of an infection embody diarrhea, vomiting, nausea and abdomen ache; folks may expertise fever, headache and physique aches. Instances with extreme vomiting and diarrhea improve the danger of great dehydration.
The Facilities for Illness Management and Prevention’s knowledge relating to norovirus outbreaks are fairly restricted: the company’s surveillance community for the an infection consists of solely 14 states. Nonetheless, the image these statistics paint is grim. The reporting states have seen 1,078 suspected or confirmed norovirus outbreaks from August 1, 2024, by way of January 15, 2025, which is sort of twice as many as the identical interval throughout the 2023–2024 season and better than in all years since not less than 2012, when the reporting community was established.
Younger youngsters and folks aged 65 and older are significantly weak to extreme sickness. Every year the virus causes greater than two million outpatient clinic visits, predominantly in younger youngsters, and kills about 900 folks a 12 months, principally these aged 65 and older. The an infection is extremely contagious, causes massive outbreaks usually and hits these weak teams arduous—however for most individuals, signs solely final just a few days. That variability in illness severity presents a tough scenario for would-be vaccine producers, says Ming Tan, a scientific researcher on the Cincinnati Kids’s Hospital Medical Middle.
“Some folks don’t view it as an important illness, and different folks say that it’s horrible as a result of it might make lots of people sick in sure shut settings,” Tan says.
Challenges for Vaccine Makers
The virus boasts a number of traits that make it a difficult goal for vaccine builders. First, as with influenza, “norovirus” is definitely a bunch of viruses that consists of some 48 so-called genotypes divided into 10 bigger lessons. As with the flu, an immune system skilled to acknowledge one number of norovirus can’t essentially shield in opposition to the others. And dominant strains come and go as continuously as each two to 4 years, making it tough for the immune system to maintain up. (Instances this 12 months and final 12 months have been induced predominantly by a pressure known as GII.17, whereas earlier seasons had been led by a pressure nicknamed Sydney.)
“There are dozens of genotypes of norovirus that may trigger illness in people, and every a type of genotypes has a barely different-looking protein shell that we expect requires a barely totally different immune response,” says Doran Fink, a doctor and vaccine scientist on the biotech firm Moderna, who leads its norovirus vaccine growth.
One other problem is that norovirus causes what scientists name a mucous membrane, or mucosal, an infection—on this case, a neighborhood an infection within the intestinal floor tissue. (Flu is a localized mucosal an infection in respiratory tissue.)
These native viruses are trickier for the physique to recollect and struggle off in contrast with systemic infections, resembling measles and chickenpox, that have an effect on the entire physique and normally trigger strong, long-lasting immune responses. “Mucosal immunity is short-lived, not like systemic immunity,” says Lijuan Yuan, a viral immunologist at Virginia Tech. An injected vaccine triggers a systemic immune response, she notes, not a mucosal one, so it’s much less capable of entry the virus. This disconnect makes it extra doubtless that injected vaccines for mucosal infections will solely shield in opposition to extreme illness, not stop illness totally.
Norovirus can also be tough to work with within the lab. Preliminary vaccine experiments sometimes require animal fashions, however researchers don’t have a superb such mannequin for norovirus. That’s as a result of human noroviruses don’t simply infect animals, and animal-specific noroviruses trigger very totally different signs. Norovirus can’t be grown properly in cells both, Yuan notes.
Within the Pipeline
Regardless of the host of obstacles, scientists are engaged on medical trials testing half a dozen totally different vaccine candidates. All goal the first floor protein—or capsid protein—that encases a norovirus molecule, however they use a number of totally different approaches, every with its personal strengths and weaknesses.
In a single method, scientists produce many of those so-called capsid proteins. The proteins then spontaneously type empty buildings in the identical form because the virus. When these empty shells, known as viruslike particles, are injected into an individual, the physique reacts as it will to the true factor, coaching the immune system. However making the viruslike particles is time-consuming, Tan says. And though the vaccine produced first rate leads to trials in adults, it did little to guard youngsters, suggesting that this weak inhabitants might require a special vaccine.
A second method recruits a standard, sometimes delicate respiratory virus known as an adenovirus, makes it unable to copy and provides it the power to supply the goal norovirus protein. The adenovirus is packaged into an oral vaccine, which is way simpler to manage than an injection, and it might practice the mucosal immune system straight. The safety fee continues to be relatively low, nevertheless, Tan says.
The third method makes use of the identical mRNA expertise that was used to create among the COVID vaccines. Genetic info for the norovirus protein is injected into the vaccine recipient to set off the immune response. This technique is easier to execute and might be extra simply up to date as totally different strains of norovirus develop into dominant, Fink says. His staff at Moderna designed an mRNA norovirus vaccine, and the corporate is now recruiting folks to check how protecting it’s. That can allow scientists to match the mRNA approach with the viruslike particle and adenovirus approaches which have disenchanted researchers to this point. “Whether or not or not it is going to have a greater efficacy, we nonetheless want to attend [and see],” says Tan, who shouldn’t be concerned with any of those candidates.
Whichever vaccine makes it by way of trials first might not earn the annual ritual standing of the flu shot. A norovirus vaccine would doubtless be supplied first to folks aged 65 years and older in addition to immunocompromised folks, provided that norovirus infections are typically a lot worse for these teams, Fink says. It could in all probability be supplied as a yearly dose timed with the height interval for norovirus, which is between November and April within the Northern Hemisphere. Maybe folks planning to embark on a cruise or those that in any other case count on to be uncovered to the virus might go for a dose as properly, he notes. However Tan isn’t satisfied that wholesome adults can be very all for a norovirus vaccine.
Fink says that there’s nonetheless worth in having a vaccine as a prevention possibility, even when it gained’t be absolutely protecting. “If we are able to shift the burden of illness such that even if you happen to do get norovirus, it’s very delicate, I feel that might be a giant success,” he says.
